Genmab Feed

Land	Danmark
Lista	Large Cap Copenhagen
Sektor	Hälsovård
Industri	Bioteknik

2023-01-24 20:00:59 Grant of Restricted Stock Units and Warrants to Employees in Genmab -1,68% | 242 MDKK

2023-01-24 12:27:35 Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022 -1,51% | 345 MDKK

2023-01-19 17:00:24 Correction to Company Announcement No. 1 of January 3, 2023 +1,18% | 285 MDKK

2023-01-03 18:31:06 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons -2,39% | 273 MDKK

2023-01-02 13:56:29 Genmab to Present at the 41st Annual J.P. Morgan Healthcare Conference +2,04% | 170 MDKK

2022-12-21 13:00:00 Genmab Announces Submission of Japan New Drug Application (JNDA) for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) -0,86% | 421 MDKK

2022-12-14 21:20:52 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons -0,94% | 367 MDKK

2022-12-13 21:05:44 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons -0,66% | 546 MDKK

2022-12-13 20:58:49 Capital Increase in Genmab as a Result of Employee Warrant Exercise -0,66% | 546 MDKK

2022-12-12 14:23:16 Genmab to Hold 2022 R&D Update and ASH Data Review Meeting +1,21% | 362 MDKK

2022-12-11 23:30:00 Genmab Showcases Data From Robust Development Program Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients Across a Broad Range of B-Cell Lymphomas at the 64th Annual ASH Meeting +1,21% | 362 MDKK

2022-11-23 20:56:09 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons +1,81% | 265 MDKK

2022-11-21 20:44:52 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons -0,76% | 235 MDKK

2022-11-21 20:39:06 Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab -0,76% | 235 MDKK

2022-11-21 14:00:00 Genmab Announces U.S. Food and Drug Administration Accepts for Priority Review Biologics License Application (BLA) for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) +1,31% | 257 MDKK

2022-11-15 19:54:46 Capital Increase in Genmab as a Result of Employee Warrant Exercise -0,26% | 256 MDKK

2022-11-14 18:30:45 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons +1,35% | 303 MDKK

2022-11-10 14:27:11 Genmab to Present at Jefferies London Healthcare Conference +4,80% | 1092 MDKK

2022-11-09 17:01:37 Genmab Announces Financial Results for the First Nine Months of 2022 +4,80% | 1092 MDKK

2022-11-03 17:45:11 Genmab Improves Its 2022 Financial Guidance +0,82% | 440 MDKK

2022-11-03 14:01:00 Genmab Announces Multiple Abstracts to be Presented at the 64th Annual Meeting and Exposition of the American Society of Hematology (ASH) +0,68% | 188 MDKK

2022-10-28 14:45:00 Genmab Announces Submissions of Regulatory Applications for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) and Diffuse Large B-Cell Lymphoma (DLBCL) +1,89% | 233 MDKK

2022-10-18 12:35:38 Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Third Quarter of 2022 +1,00% | 312 MDKK

2022-10-05 21:56:40 Major Shareholder Announcement +4,14% | 367 MDKK

2022-09-27 18:43:29 Capital Increase in Genmab as a Result of Employee Warrant Exercise +0,57% | 234 MDKK

2022-09-20 21:20:55 Grant of Restricted Stock Units and Warrants to Employees in Genmab +1,12% | 176 MDKK

2022-09-06 16:53:48 Genmab to Present at Morgan Stanley 20th Annual Global Healthcare Conference -0,19% | 187 MDKK

2022-09-01 18:27:13 Completion of share buy-back program +3,70% | 339 MDKK

2022-08-29 11:04:41 Transactions in connection with share buy-back program -2,87% | 274 MDKK

2022-08-24 20:52:50 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons -0,22% | 264 MDKK

2022-08-22 11:50:04 Transactions in connection with share buy-back program -0,79% | 217 MDKK

2022-08-17 19:19:34 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons -2,11% | 209 MDKK

2022-08-16 20:26:13 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons +0,26% | 235 MDKK

2022-08-16 20:22:37 Capital Increase in Genmab as a Result of Employee Warrant Exercise +0,26% | 235 MDKK

2022-08-15 09:42:26 Transactions in connection with share buy-back program +2,12% | 195 MDKK

2022-08-10 17:01:39 Genmab Announces Financial Results for the First Half of 2022 +5,38% | 543 MDKK

2022-08-08 18:33:17 Genmab Improves Its 2022 Financial Guidance +0,23% | 233 MDKK

2022-08-08 10:18:18 Transactions in connection with share buy-back program +0,27% | 236 MDKK

2022-08-05 12:45:00 Genmab and BioNTech Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates -2,37% | 290 MDKK

2022-08-02 20:46:23 Major Shareholder Announcement +1,46% | 309 MDKK

2022-08-01 13:41:29 Transactions in connection with share buy-back program -0,12% | 311 MDKK

2022-07-25 13:50:01 Transactions in connection with share buy-back program -2,23% | 230 MDKK

2022-07-20 19:03:08 Major Shareholder Announcement +1,40% | 245 MDKK

2022-07-19 12:33:55 Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Second Quarter of 2022 +2,25% | 387 MDKK

2022-07-18 16:01:41 Genmab Announces That AbbVie Will Submit Marketing Authorization Application to European Medicines Agency for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) -0,04% | 176 MDKK

2022-07-18 13:27:45 Transactions in connection with share buy-back program -0,04% | 176 MDKK

2022-07-11 17:28:06 Major Shareholder Announcement -1,64% | 262 MDKK

2022-07-11 10:50:43 Transactions in connection with share buy-back program +0,12% | 182 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2023-11-07	Kvartalsrapport 2023-Q3
2023-08-03	Kvartalsrapport 2023-Q2
2023-05-10	Kvartalsrapport 2023-Q1
2023-03-29	Årsstämma 2023
2023-02-22	Bokslutskommuniké 2022
2022-11-09	Kvartalsrapport 2022-Q3
2022-08-10	Kvartalsrapport 2022-Q2
2022-05-11	Kvartalsrapport 2022-Q1
2022-03-30	Ordinarie utdelning GMAB 0.00 DKK
2022-03-29	Årsstämma 2022
2022-02-16	Bokslutskommuniké 2021
2021-11-10	Kvartalsrapport 2021-Q3
2021-08-11	Kvartalsrapport 2021-Q2
2021-05-05	Kvartalsrapport 2021-Q1
2021-04-14	Ordinarie utdelning GMAB 0.00 DKK
2021-04-13	Årsstämma 2021
2021-02-23	Bokslutskommuniké 2020
2020-11-04	Kvartalsrapport 2020-Q3
2020-08-12	Kvartalsrapport 2020-Q2
2020-05-06	Kvartalsrapport 2020-Q1
2020-03-27	Ordinarie utdelning GMAB 0.00 DKK
2020-03-26	Årsstämma 2020
2020-02-19	Bokslutskommuniké 2019
2019-04-01	Ordinarie utdelning GMAB 0.00 DKK
2019-03-29	Årsstämma 2019
2018-11-14	Kvartalsrapport 2018-Q3
2018-08-08	Kvartalsrapport 2018-Q2
2018-05-08	Kvartalsrapport 2018-Q1
2018-04-11	Ordinarie utdelning GMAB 0.00 DKK
2018-04-10	Årsstämma 2018
2018-02-21	Bokslutskommuniké 2017
2017-11-08	Kvartalsrapport 2017-Q3
2017-08-09	Kvartalsrapport 2017-Q2
2017-05-10	Kvartalsrapport 2017-Q1
2017-03-29	Ordinarie utdelning GMAB 0.00 DKK
2017-03-28	Årsstämma 2017
2017-02-22	Bokslutskommuniké 2016
2016-11-10	Kapitalmarknadsdag 2016
2016-11-02	Kvartalsrapport 2016-Q3
2016-08-09	Kvartalsrapport 2016-Q2
2016-05-10	Kvartalsrapport 2016-Q1
2016-03-18	Ordinarie utdelning GMAB 0.00 DKK
2016-03-17	Årsstämma 2016
2016-02-17	Bokslutskommuniké 2015
2015-11-03	Kvartalsrapport 2015-Q3
2015-08-11	Kvartalsrapport 2015-Q2
2015-05-12	Kvartalsrapport 2015-Q1
2015-03-27	Ordinarie utdelning GMAB 0.00 DKK
2015-03-26	Årsstämma 2015
2015-03-02	Bokslutskommuniké 2014
2014-04-10	Ordinarie utdelning GMAB 0.00 DKK
2013-04-18	Ordinarie utdelning GMAB 0.00 DKK
2012-04-26	Ordinarie utdelning GMAB 0.00 DKK
2011-04-07	Ordinarie utdelning
2010-04-22	Ordinarie utdelning

Genmab

Kalender

Beskrivning

Genmab

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden